Diabetic gastroparesis: a disease for which long-term therapeutic benefits are difficult to obtain
Citations Over Time
Abstract
The pathophysiology of diabetic gastroparesis (DGP), a common complication in diabetic patients, is not fully known. Its development has been linked to several causes, including hyperglycaemia, vagal nerve dysfunction, aberrant Cajal's interstitial cell network (ICC), lack of nerve nitric oxide synthase (nNOS) expression in the intermuscular plexus, and hormonal alterations in the gastrointestinal tract. Glucose management, diet control, gastric stimulants, anti-emetic medications, Helicobacter pylori eradication, stomach electrical stimulation, and surgery are the main current treatments. These methods, however, could have unfavourable consequences. By examining recent studies and literature reviews, we outline the state of the study on diabetic gastroparesis in this paper.
Related Papers
- → Interstitial cells of Cajal generate a rhythmic pacemaker current(1998)440 cited
- → Clinical‐histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium(2012)208 cited
- → The Significance of Interstitial Cells in Neurogastroenterology(2014)126 cited
- → Interstitial Cells in the Musculature of the Gastrointestinal Tract: Cajal and Beyond(2003)101 cited
- → Is Interstitial Cells of Cajal‒opathy Present in Gastroparesis?(2015)46 cited